TMPRSS2 and cancer: This TMPRSS2-ERG positive case had a somatic missense mutation in MED12 (c.3670C > G; p.Leu1224Val), that is potentially pathogenic in many cancers, including prostate [48], via its upregulation of Wnt/β-catenin signalling [49].